Maintenance Rituximab Reduces Relapse in Phospholipase A2 Receptor (PLA2R)-Related Membranous Nephropathy: A Retrospective Cohort Study (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #TH-PO1264; Pres time: Oct 22, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall; "Complete remission and maintenance rituximab were independently associated with relapse in PLA2R-related PMN patients treated with rituximab. Pursuing for complete remission and reeiving maintenance rituximab may help maintain remission and reduce relapse in PLA2R-related PMN, which required further validation in future RCTs."
Late-breaking abstract • Retrospective data • Glomerulonephritis • Renal Disease
|
|
Jingyuan Xie1; Xiaofan Hu1
|